Home » Topics » Regulatory » Patents

Patents
RSS

Rapamycin esters from American Home Products

July 26, 1996

Immunoregulatory peptides with special binding properties

July 26, 1996

HSV proteins as immune resonse regulators

July 26, 1996

Erythropoietin claimed as chronic inflammation treatment

July 26, 1996

Matrix metalloproteinase inhibitors described by British Biotech

July 26, 1996

Monoclonal antibody fragments as immunosuppressants

July 26, 1996

COX-2 inhibitors described to treat inflammation

July 26, 1996

Xoma claims rBPI21 + antibiotic combination for Gram-negative infections

July 26, 1996

Carbapenem derivatives with antibacterial activity claimed by Yamanouchi

July 26, 1996

Human Genome Sciences claims VIGF polypeptide technology

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...